Sage Therapeutics, Inc. Other Non-Current Assets
Sage Therapeutics, Inc. had Other Non-Current Assets of $1.76 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2025-07-30
- 2025-06-30: Other Assets, Noncurrent $1.76M.
- 2025-03-31: Other Assets, Noncurrent $2.61M.
- 2024-12-31: Other Assets, Noncurrent $2.83M.
- 2024-09-30: Other Assets, Noncurrent $5.17M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2025-06-30 | $1.76M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $2.61M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $2.83M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $5.17M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $7.80M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $6.22M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $6.55M 10-K · filed 2025-02-11 |
| 2023-09-30 | $6.59M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.89M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $4.25M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $4.77M 10-K · filed 2024-02-14 |
| 2022-09-30 | $4.91M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.91M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $4.59M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $4.25M 10-K · filed 2023-02-16 |
| 2021-09-30 | $3.88M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $3.60M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $3.39M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $3.34M 10-K · filed 2022-02-24 |
| 2020-09-30 | $3.43M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.42M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.69M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.79M 10-K · filed 2021-02-24 |
| 2019-09-30 | $3.82M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.02M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $4.38M 10-Q · filed 2019-05-02 |